NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Qitan Tech

Qitan Tech

Private
ChengduHealthcare & Life Scienceshttps://qitantech.com/

Last Round

Series C

Extension

Dec 28, 2023

Total Funding Raised

$203.27M

Company Overview

Qitan Tech is a biotechnology company that develops and manufactures nanopore gene sequencing platforms, flow cells, and reagents.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Data as a Service

AI Layer

Application

Keywords

nanopore sequencinglong-read sequencingDNA sequencingRNA sequencingnext-gen sequencinggenomic analysisNGSbasecallinggenomicssequencing consumablespathogen identificationbiotech equipmentbioinformaticsprecision medicineportable sequencer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Qitan Tech Comparables

Compare Qitan Tech with similar companies based on industry and business-model similarity.

Qitan Tech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Geneus Technologies (Chengdu) Co., Ltd.
88%
Anxuyuan Biotechnology (Shenzhen) Co., Ltd.
85%
Ruhan Gene Tech
80%

Qitan Tech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionDec 28, 2023
Series CDec 23, 2022
Series BJun 8, 2021
Series AMay 13, 2020
Pre SeedAug 8, 2019

Qitan Tech Investors

Notable investors and investment history

Qitan Tech investors
InvestorRounds
BioTrack CapitalSeries B, Series C
Ceyuan VenturesSeries C Extension
Yinxinggu CapitalSeries B, Series A
Hillhouse InvestmentSeries B
Baidu VenturesSeries B, Seed
Huagai CapitalSeries B, Series C
Empower InvestmentSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 28, 2023

    Raised $14M with Ceyuan Ventures and cdbtgroup participating.

  • Dec 23, 2022

    $100M round led by Meituan.

Qitan Tech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Qitan Tech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Qitan Tech's valuation, stock price, and market status.

Firmographic Details

HeadquartersChengdu
Employee Range7
Year Founded2016
Last FundingDec 28, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.